Research suggests that Albizia bark may support sleep quality, though the available evidence is limited to a single preclinical animal study conducted in 2021. In that study, Albizia bark was tested as part of a multi-herb traditional Chinese medicine decoction in a mouse model of insomnia, where the combination appeared to improve sleep duration, reduce activity levels, and ease depression-like behaviors, with effects potentially linked to changes in serotonin, dopamine, and related neurotransmitters in the brain. Because Albizia was studied alongside three other herbs rather than in isolation, it is not possible to attribute the observed effects to Albizia alone. The absence of human clinical trials means these findings, while directionally promising, cannot yet be generalized to people, and further research isolating Albizia's individual contribution would be needed to draw firmer conclusions.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Nyctinastic herbs decoction improves para-chlorophenylalanine-induced insomni... | Other | 2021 | Supports | 100 |